top
Search terms
Results 1 - 2 of 2 - ordered by :
Escardio

(1) Professor Keith Fox, principal investigator, University of Edinburgh, UK, said: “These findings challenge the use of combined oral anticoagulant and antiplatelet therapy in patients with ...

Date : 28/08/2018
Escardio

Prof. Zannad points out that, “Rivaroxaban is approved at higher doses to treat conditions such as atrial fibrillation (AF) and venous thromboembolism, but in COMMANDER HF, patients were ...

Date : 28/08/2018